Herbas VPB

Print
EN | LT
LT - FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
EN - FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 471/16 (2006.01)
A61K 31/427 (2013.01)
A61K 31/5025 (2006.01)
A61K 31/4402 (2013.01)
A61P 31/18 (2006.01)
A61K 31/4985 (2013.01)
A61K 31/505 (2013.01)
A61K 31/513 (2013.01)
A61K 31/52 (2013.01)
A61K 31/5365 (2013.01)
A61K 31/635 (2013.01)
A61K 31/683 (2013.01)
C07D 471/16 (2013.01)
A61P 31/00 (2018.01)
A61P 31/18 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3397639
(13) Kind of document T
(96) European patent application number 16826561.9
Date of filing the European patent application 2016-12-22
(97) Date of publication of the European application 2018-11-07
(45) Date of publication and mention of the grant of the patent 2022-02-23
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2016/068173
Date 2016-12-22
PCT application publication
(87) Number WO 2017/116928
Date 2017-07-06
Priority applications
(30) Number Date Country code
PCT/CN2015/100106 2015-12-31 WO
Inventors
(72)
YU, Tao , US
WADDELL, Sherman, T. , US
GRAHAM, Thomas, H. , US
ZHANG, Yonglian , US
MCCAULEY, John, A. , US
STAMFORD, Andrew, W. , US
CAI, Jiaqiang , CN
QI, Zhiqi , CN
Grantee
(73) Merck Sharp & Dohme Corp. , 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
Title
(54) FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
  FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS